Why NRx Pharmaceuticals Stock Is Tumbling Today
Shares of NRx Pharmaceuticals (NASDAQ: NRXP) were trading 7.2% lower as of 11:25 a.m. EDT Friday. The decline came after the drugmaker submitted prospectus supplements on Thursday with the Securities and Exchange Commission.
These filings stated that NRx sent a letter to shareholders on Wednesday addressing a lawsuit recently initiated by Relief Therapeutics (OTC: RLFT.F) in New York State Court. Relief alleges that NRx "failed to honor its obligations" under a collaboration agreement between the two companies related to the development of Zyesami (aviptadil).
Image source: Getty Images.
Source Fool.com
